Saudi says no MERS infections during Ramadan pilgrimage

A large influx of Muslim pilgrims on Saudi Arabia during the fasting month of Ramadan passed without any cases of the MERS coronavirus infection reported, authorities said Tuesday.

"No infections by the MERS coronavirus or any other epidemic diseases" have been reported among "pilgrims and visitors in (the holy sites of) Mecca and Medina," Health Minister Abdullah al-Rabia said.

The numbers of pilgrims and visitors during Ramadan that began on July 10 and ended on Thursday five million, of whom only 200,000 remain in the kingdom, he said in a statement carried by the official SPA news agency.

The minor pilgrimage, or umrah, takes place all year round, but the busiest time is during Ramadan.

The virus has killed 46 of the 94 people confirmed infected since September worldwide, most of them in Saudi Arabia.

The exact origins of the virus is a riddle scientists have been working hard to solve in a bid to halt its spread, especially in the lead-up to the annual hajj pilgrimage to Saudi Arabia in October.

Concerns about the virus, for which there is no vaccine, have led Saudi Arabia to restrict visas for the 2013 hajj, which sees millions of Muslims flock to Mecca and Medina every year.

MERS is considered a cousin of the SARS virus that erupted in Asia in 2003 and infected 8,273 people, nine percent of whom died.

Like SARS, it is thought to have jumped from animals to humans, and shares the former's flu-like symptoms—but differs by causing .

On Friday, researchers pointed to the Arabian, or dromedary, camel as a possible host of the virus.

Scientists studying the have found older patients, men, and people with underlying medical conditions are those particularly at risk.

add to favorites email to friend print save as pdf

Related Stories

Saudi man dies of MERS virus: ministry

Jul 28, 2013

A Saudi man has died of the coronavirus MERS and another has contracted the virus, the health ministry said on Saturday, bringing the kingdom's deaths from the virus to 39.

Virus fears, Mecca work downsizes hajj pilgrimage

Jul 25, 2013

Fears of an outbreak of the deadly MERS virus in Saudi Arabia and construction in the holy city of Mecca have forced cuts in the numbers of pilgrims permitted to perform this year's hajj.

Two new MERS deaths in Saudi: ministry

Jul 07, 2013

A Saudi man and a child have died from the MERS virus, bringing the number of deaths from the respiratory infection in the kingdom to 38, the health ministry said on Sunday.

Recommended for you

S.Korea detects second foot-and-mouth case

28 minutes ago

South Korea on Monday reported its second case of foot-and-mouth disease in less than a week, triggering fearful memories of a devastating 2011 outbreak that forced the culling of millions of livestock.

Ebola kills Liberian doctor, 2 Americans infected

58 minutes ago

(AP)—One of Liberia's most high-profile doctors has died of Ebola, officials said Sunday, and an American physician was being treated for the deadly virus, highlighting the risks facing health workers trying ...

Hepatitis C virus genotype 1 is most prevalent worldwide

1 hour ago

In one of the largest prevalence studies to date, researchers from the U.K. provide national, regional, and global genotype prevalence estimates for the hepatitis C virus (HCV). Findings published in Hepatology, a journa ...

1 in 3000 blood donors in England infected with hepatitis E

1 hour ago

The first systematic analysis of hepatitis E virus (HEV) transmission by blood components indicates that about 1 in 3000 donors in England have HEV in their plasma. The findings, published in The Lancet, suggest that around ...

Biologic treatments for RA carry similar infection risk

1 hour ago

(HealthDay)—The risk of hospitalized bacterial infections in older rheumatoid arthritis (RA) patients is similar for rituximab or abatacept compared to etanercept, although it is higher for infliximab, ...

New oral drug regimens cure hardest-to-treat hepatitis C

2 hours ago

Two new pill-only antiviral drug regimens could provide shorter, more effective treatment options with fewer side effects for the majority of patients infected with hepatitis C, even those most difficult to treat, according ...

User comments